ArticleBiomedical reports2024

Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96‑week retrospective study.

Serena Spampinato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.